[1]
R. Thottol, M. Sreelatha, and P. Narayanan, “Open label study to assess the safety and efficacy of cinacalcet in refractory hyperparathyroidism with chronic renal failure”, Int J Basic Clin Pharmacol, vol. 5, no. 3, pp. 676–683, Dec. 2016.